Hemorrhagic Complications of Anticoagulant and Thrombolytic Treatment : American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)SCHULMAN, Sam; BEYTH, Rebecca J; KEARON, Clive et al.Chest. 2008, Vol 133, Num 6, issn 0012-3692, 257.S-298.S, SUPArticle

Hemorrhagic complications of anticoagulant treatmentLEVINE, Mark N; RASKOB, Gary; LANDEFELD, Seth et al.Chest. 2001, Vol 119, Num 1, pp 108S-121S, issn 0012-3692, SUPArticle

Breast CancerLEVINE, Mark N; GANZ, Patricia A; MAMOUNAS, Eleftherios P et al.Journal of clinical oncology. 2008, Vol 26, Num 5, issn 0732-183X, [127 p.]Serial Issue

Epidemiology of thrombosis in cancerRICKLES, Frederick R; LEVINE, Mark N.Acta haematologica. 2001, Vol 106, Num 1-2, pp 6-12, issn 0001-5792Article

Dalteparin Low Molecular Weight Heparin (LMWH) in ovarian cancer: A phase II randomized studyELIT, Laurie M; LEE, Agnes Y; PARPIA, Sameer et al.Thrombosis research. 2012, Vol 130, Num 6, pp 894-900, issn 0049-3848, 7 p.Article

Implementing a Survivorship Care Plan for Patients With Breast CancerGANZ, Patricia A; HAHN, Erin E.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 759-767, issn 0732-183X, 9 p.Article

Preoperative Therapy in Invasive Breast Cancer : Pathologic Assessment and Systemic Therapy Issues in Operable DiseaseGRALOW, Julie R; BURSTEIN, Harold J; WINER, Eric P et al.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 814-819, issn 0732-183X, 6 p.Article

Randomized trial of long-term follow-up for early-stage breast cancer : A comparison of family physician versus specialist careGRUNFELD, Eva; LEVINE, Mark N; GINSBURG, David et al.Journal of clinical oncology. 2006, Vol 24, Num 6, pp 848-855, issn 0732-183X, 8 p.Article

Why cancer patients enter randomized clinical trials: Exploring the factors that influence their decisionWRIGHT, James R; WHELAN, Timothy J; LEVINE, Mark N et al.Journal of clinical oncology. 2004, Vol 22, Num 21, pp 4312-4318, issn 0732-183X, 7 p.Article

Chromosome 17 centromere (CEP17) duplication as a predictor of anthracycline response: evidence from the NCIC Clinical Trials Group (NCIC CTG) MA.5 TrialPRITCHARD, Kathleen I; MUNRO, Alison; O'MALLEY, Frances P et al.Breast cancer research and treatment. 2012, Vol 131, Num 2, pp 541-551, issn 0167-6806, 11 p.Article

Evaluating Survivorship Care Plans: Results of a Randomized, Clinical Trial of Patients With Breast CancerGRUNFELD, Eva; JULIAN, Jim A; PORTER, Geoffrey A et al.Journal of clinical oncology. 2011, Vol 29, Num 36, pp 4755-4762, issn 0732-183X, 8 p.Article

Sentinel Node Biopsy : Interpretation and Management of Patients With Immunohistochemistry-Positive Sentinel Nodes and Those With MicrometastasesRUTGERS, Emiel J. T.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 698-702, issn 0732-183X, 5 p.Article

Clinical Application of the 70-Gene Profile : The MINDACT TrialCARDOSO, Fatima; VAN'T VEER, Laura; RUTGERS, Emiel et al.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 729-735, issn 0732-183X, 7 p.Article

HER-2 and Topoisomerase II As Predictors of Response to ChemotherapyPRITCHARD, Kathleen I; MESSERSMITH, Hans; ELAVATHIL, Leela et al.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 736-744, issn 0732-183X, 9 p.Article

Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancerLEE, Agnes Y. Y; LEVINE, Mark N; KOVACS, Michael J et al.The New England journal of medicine. 2003, Vol 349, Num 2, pp 146-153, issn 0028-4793, 8 p.Article

Expectant Management Versus Immediate Treatment for Low-Grade Cervical Intraepithelial Neoplasia: A Randomized Trial in Canada and BrazilELIT, Laurie; LEVINE, Mark N; JULIAN, Jim A et al.Cancer. 2011, Vol 117, Num 7, pp 1438-1445, issn 0008-543X, 8 p.Article

Long-Term Results of Hypofractionated Radiation Therapy for Breast CancerWHELAN, Timothy J; PIGNOL, Jean-Philippe; PERERA, Francisco et al.The New England journal of medicine. 2010, Vol 362, Num 6, pp 513-520, issn 0028-4793, 8 p.Article

Who Should Have Breast Magnetic Resonance Imaging Evaluation?OREL, Susan.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 703-711, issn 0732-183X, 9 p.Article

Behavioral Symptoms in Patients With Breast Cancer and SurvivorsBOWER, Julienne E.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 768-777, issn 0732-183X, 10 p.Article

Advances in Adjuvant Endocrine Therapy for Postmenopausal WomenLIN, Nancy U; WINER, Eric P.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 798-805, issn 0732-183X, 8 p.Article

Research Issues Affecting Preoperative Systemic Therapy for Operable Breast CancerWOLFF, Antonio C; BERRY, Donald; SMITH, Mary Lou et al.Journal of clinical oncology. 2008, Vol 26, Num 5, pp 806-813, issn 0732-183X, 8 p.Article

Low molecular weight heparin, therapy with dalteparin, and survival in advanced cancer: The fragmin advanced malignancy outcome study (FAMOUS)KAKKAR, Ajay K; LEVINE, Mark N; KADZIOLA, Zbigniew et al.Journal of clinical oncology. 2004, Vol 22, Num 10, pp 1944-1948, issn 0732-183X, 5 p.Article

Funding Oncology Clinical Trials: Are Cooperative Group Trials Sustainable?SEOW, Hsien-Yeang; WHELAN, Patrick; LEVINE, Mark N et al.Journal of clinical oncology. 2012, Vol 30, Num 13, pp 1456-1461, issn 0732-183X, 6 p.Article

Prospective Study of 2-[¹⁸F]Fluorodeoxyglucose Positron Emission Tomography in the Assessment of Regional Nodal Spread of Disease in Patients With Breast Cancer: An Ontario Clinical Oncology Group StudyPRITCHARD, Kathleen I; JULIAN, Jim A; O'MALLEY, Frances P et al.Journal of clinical oncology. 2012, Vol 30, Num 12, pp 1274-1279, issn 0732-183X, 6 p.Article

Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast CancerBURNELL, Margot; LEVINE, Mark N; RUGO, Hope et al.Journal of clinical oncology. 2010, Vol 28, Num 1, pp 77-82, issn 0732-183X, 6 p.Article